BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38326203)

  • 1. Plasma Concentration of Antifungal Agent Micafungin for Pediatric Living Donor Liver Transplantation.
    Ueno T; Takase K; Deguchi K; Nomura M; Watanabe M; Kamiyama M; Tazuke Y; Kimura T; Okuyama H
    Transplant Proc; 2024 Apr; 56(3):602-604. PubMed ID: 38326203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-D-Glucan Levels With Use of an Anti-adhesion Barrier Film in Pediatric Living Donor Liver Transplantation.
    Ueno T; Kodama T; Noguchi Y; Deguchi K; Nomura M; Saka R; Watanabe M; Tazuke Y; Bessho K; Okuyama H
    Transplant Proc; 2020; 52(6):1818-1820. PubMed ID: 32571708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.
    Mehta PA; Vinks AA; Filipovich A; Bleesing J; Jodele S; Jordan MB; Marsh R; Tarin R; Edwards S; Fearing D; Lawrence J; Davies SM
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1458-62. PubMed ID: 20546908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of total bilirubin on plasma micafungin levels in living-donor liver transplantation recipients with severe liver dysfunction.
    Muraki Y; Iwamoto T; Kagawa Y; Sakurai H; Usui M; Isaji S; Uemoto S; Okuda M
    Biol Pharm Bull; 2009 Apr; 32(4):750-4. PubMed ID: 19336919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
    Yoshikawa K; Nakazawa Y; Katsuyama Y; Hirabayashi K; Saito S; Shigemura T; Tanaka M; Yanagisawa R; Sakashita K; Koike K
    Infection; 2014 Aug; 42(4):639-47. PubMed ID: 24567233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Everolimus Rescue Treatment After Pediatric Living Donor Liver Transplantation.
    Ueno T; Kodama T; Noguchi Y; Deguchi K; Nomura M; Saka R; Watanabe M; Tazuke Y; Bessho K; Okuyama H
    Transplant Proc; 2020; 52(6):1829-1832. PubMed ID: 32571711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factors affecting the pharmacokinetics after living donor liver transplant].
    Muraki Y
    Yakugaku Zasshi; 2012; 132(9):1011-7. PubMed ID: 23023417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcome After Tacrolimus-Related Neurotoxicity in Pediatric Living Donor Liver Transplantation.
    Ueno T; Toyama C; Deguchi K; Masahata K; Nomura M; Watanabe M; Kamiyama M; Tazuke Y; Bessho K; Okuyama H
    Transplant Proc; 2022 Mar; 54(2):468-471. PubMed ID: 35074159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of Micafungin Use in Children].
    Yeşil E; Çelebi S; Sezgin Evim M; Özer A; Turan C; Timur D; Çakır SÇ; Bülbül B; Ener B; Güneş AM; Köksal N; Özkan H; Sevinir B; Düzcan Kilimci D; Hacımustafaoğlu M
    Mikrobiyol Bul; 2020 Jan; 54(1):120-134. PubMed ID: 32050883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micafungin twice weekly as antifungal prophylaxis in paediatric patients at high risk for invasive fungal disease.
    Bochennek K; Balan A; Müller-Scholden L; Becker M; Farowski F; Müller C; Groll AH; Lehrnbecher T
    J Antimicrob Chemother; 2015 May; 70(5):1527-30. PubMed ID: 25564562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients.
    Walsh TJ; Goutelle S; Jelliffe RW; Golden JA; Little EA; DeVoe C; Mickiene D; Hayes M; Conte JE
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3451-9. PubMed ID: 20439610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroids and living liver donation increase tacrolimus blood levels in living donor liver transplantation.
    Charco R; Rimola A; García-Valdecasas JC; Fuster J; Fondevila C; Navasa M; Julian M; Forta V; Brunet M
    Transplant Proc; 2005 Nov; 37(9):3930-1. PubMed ID: 16386588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Why might micafungin be the drug of choice in pediatric patients?].
    Ramos Amador JT; Prieto Tato L; Guillén Martín S
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():23-8. PubMed ID: 21420573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
    Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
    Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis.
    Auriti C; Falcone M; Ronchetti MP; Goffredo BM; Cairoli S; Crisafulli R; Piersigilli F; Corsetti T; Dotta A; Pai MP
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7333-7339. PubMed ID: 27697761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal prophylactic dosage and disposition of micafungin in living donor liver recipients.
    Kishino S; Ohno K; Shimamura T; Furukawatodo H
    Clin Transplant; 2004 Dec; 18(6):676-80. PubMed ID: 15516243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients.
    Carter NJ; Keating GM
    Paediatr Drugs; 2009; 11(4):271-91. PubMed ID: 19566111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients.
    Takatsuki M; Chen CL; Chen YS; Wang CC; Lin CC; Yang CH; Yong CC; Liu YW
    Clin Transplant; 2004 Dec; 18(6):694-9. PubMed ID: 15516246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pre-Kasai procedure in living donor liver transplantation for children with biliary atresia.
    Wang Q; Yan LN; Zhang MM; Wang WT; Zhao JC; Pu CL; Li YC; Kang Q
    Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):47-53. PubMed ID: 23392798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Change Rate of Tacrolimus Clearance During Continuous Intravenous Infusion and Recipient Recovery at an Early Stage After Living Donor Liver Transplantation.
    Nakagawa J; Ishido K; Tono Y; Kimura N; Wakiya T; Okamura Y; Hakamada K; Niioka T
    Eur J Drug Metab Pharmacokinet; 2020 Oct; 45(5):619-626. PubMed ID: 32514937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.